Skip to main content
. 2021 May 13;11(10):3244–3261. doi: 10.1016/j.apsb.2021.05.005

Figure 7.

Figure 7

In vivo antitumor and antimetastatic studies of FGP nanoparticles. (A) The relative tumor growth curves of 4T1 tumor-bearing mice after various treatments for 14 d. (B) The average tumor weight in each treatment at 14 d. (C–E) H&E staining, Ki67 immunohistochemical staining and TUNEL analysis of tumor tissues after different treatments. Scale bar = 200 μm. (F) The number of nodules on the surface of lung excised from 4T1 tumor-bearing mice. Scale bar = 500 μm. (G) Representative H&E staining of lungs. Data are presented as mean ± SD (n = 6,∗∗P < 0.01 FGP with NIR vs. other treatments).